From: Adverse events during intrahospital transport of critically ill patients: incidence and risk factors
Qualitative data | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |
Treatments before transport | ||||
Dialysis | 0.76 (0.44-1.32) | NS | ||
Sedation | 2.02 (1.22-3.34) | 0.008 | 1.85 (1.1-3.11) | 0.021 |
Neuromuscular blockers use | 1.55 (0.69-3.45) | NS | ||
Norepinephrine before transport | 1.61 (0.84-3.06) | NS | ||
Dobutamine before transport | 1.21 (0.58-2.54) | NS | ||
Ventilatory mode before IHT | ||||
VAC | 0.9 (0.48-1.69) | NS | ||
BIPAP | 0.94 (0.36-2.47) | NS | ||
PSV | 1.42 (0.65-3.11) | NS | ||
FiO2 before IHT >60% | 1.51 (0.81-2.83) | NS | ||
PEEP before IHT >6 cmH2O | 2.27 (1.34-3.85) | 0.003 | 2.28 (1.32-3.95) | 0.003 |
Transport | ||||
More than four infusion pumps for transport | 3.4 (0.88-13.03) | 0.071 | NS | |
Ventilatory mode change for transport | 1.3 (0.64-2.65) | NS | ||
Change of PEEP for transport | 0.84 (0.05-13.64) | NS | ||
Treatment modification for transport | 2.22 (1.23-4.01) | 0.011 | NS | |
Sedation for transport | 1.77 (0.88-3.55) | NS | ||
Neuromuscular blocker use for transport | 1.2 (0.44-3.29) | NS | ||
Fluid challenge for transport | 6.36 (1.37-29.64) | 0.014 | 6.48 (1.32-31.69) | 0.021 |
Quantitative data | Univariate | Multivariate | ||
Without AE | With AE | analysis | analysis | |
Patient data (Med (25 th ,75 th )) | ||||
Age (yr) | 61 (44–74) | 58 (50.5-68) | NS | |
SAPS II | 48 (34–61) | 48 (34–64) | NS | |
Transport's data (Med (25 th ,75 th )) | ||||
SOFA the day of transport | NS | |||
MV duration before transport (days) | 4 [2–11.25] | 4 [2–10.75] | NS | |
No. of infusion pumps during transport | p = 0.015 | NS |